Shares of Intuitive Surgical, Inc. ( NASDAQ:ISRG – Get Free Report ) have been assigned an average rating of “Moderate Buy” from the nineteen ratings firms that are covering the company, MarketBeat.com reports.
One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and fifteen have given a buy rating to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $554.17.
ISRG has been the topic of several recent research reports. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Robert W.
Baird increased their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th.
Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Leerink Partners increased their price objective on Intuitive Surgical from $489.00 to $502.
00 in a research report on Thursday, October 17th. Finally, Wells Fargo & Company lifted their price objective on Intuitive Surgical from $549.00 to $630.
00 and gave the company an “overweight” rating in a research note on Wednesday, December 11th. Get Our Latest Report on ISRG Intuitive Surgical Stock Down 0.9 % Intuitive Surgical ( NASDAQ:ISRG – Get Free Report ) last released its earnings results on Thursday, October 17th.
The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.
32. The company had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.
01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.
51%. As a group, research analysts anticipate that Intuitive Surgical will post 5.45 EPS for the current year.
Insider Transactions at Intuitive Surgical In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.
63, for a total transaction of $9,286,596.13. Following the transaction, the chief executive officer now owns 24,219 shares in the company, valued at approximately $12,391,166.
97. This represents a 42.84 % decrease in their position.
The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website . Also, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction on Tuesday, October 29th. The shares were sold at an average price of $506.
52, for a total value of $95,225.76. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,788,899.
12. The trade was a 3.30 % decrease in their ownership of the stock.
The disclosure for this sale can be found here . Insiders have sold a total of 48,190 shares of company stock valued at $25,012,927 in the last 90 days. Insiders own 0.
90% of the company’s stock. Institutional Inflows and Outflows Several institutional investors have recently bought and sold shares of the stock. State Street Corp raised its stake in Intuitive Surgical by 1.
4% in the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after purchasing an additional 210,363 shares during the last quarter. FMR LLC raised its position in shares of Intuitive Surgical by 8.
3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after buying an additional 838,793 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Intuitive Surgical by 1.
9% in the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after buying an additional 143,440 shares in the last quarter. Fisher Asset Management LLC boosted its position in Intuitive Surgical by 1.
8% during the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock worth $2,349,441,000 after acquiring an additional 86,208 shares during the last quarter. Finally, Baillie Gifford & Co.
grew its stake in Intuitive Surgical by 0.6% during the 3rd quarter. Baillie Gifford & Co.
now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after acquiring an additional 24,183 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.
About Intuitive Surgical ( Get Free Report Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. Featured Stories Five stocks we like better than Intuitive Surgical Special Purpose Acquisition Company (SPAC) What You Need to Know Work and Play: Investing in the Rise of Bleisure Travel Why Special Dividends Can be a Delightful Surprise for Income Investors Top Dividend Stocks to Buy Now as Bond Yields Could Lower Do ETFs Pay Dividends? What You Need to Know SAP: AI Tailwinds Accelerating Enterprise Cloud Business Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.
com's FREE daily email newsletter ..
Business
Intuitive Surgical, Inc. (NASDAQ:ISRG) Given Average Recommendation of “Moderate Buy” by Brokerages
Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) have been assigned an average rating of “Moderate Buy” from the nineteen ratings firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and fifteen have given a buy [...]